cancer research

The Cancer Research Institute is a 501(c)(3) charitable organization founded in 1953 to foster the science of cancer immunology, which is based on the premise that the body's immune system can be mobilized against cancer. This field, which CRI helped pioneer and develop, has been recognized throughout the world as offering great hope for the ultimate prevention and treatment of human cancer.

For five decades, the Institute has been a sustaining force in cancer and immunology research. The Institute has supported more than 2,780 scientists and clinicians at leading universities and research centers worldwide. All such funding decisions are made by its Scientific Advisory Council consisting of 68 of the world's leading immunologists, including 5 Nobel laureates, 28 members of the National Academy of Sciences, and 23 members of the Academy of Cancer Immunology.

As the initiator and steward of unprecedented global scientific and clinical collaborations like the Cancer Vaccine Collaborative, a joint program with the international Ludwig Institute for Cancer Research, and the Coordinated Cancer Initiatives, the Cancer Research Institute is ushering in a new era of scientific progress, hastening the discovery of effective cancer vaccines and other immune-based therapies that are providing new hope to cancer patients.

The Cancer Research Institute has one of the lowest overhead expense ratios among non-profit organizations, with the majority of its resources going directly to the support of its science, medical, and research programs. This has consistently earned CRI an A grade or higher for fiscal disclosure and efficiency from the American Institute of Philanthropy and top marks from other charity watchdog organizations